Every single machine learning (ML)-driven breakthrough, from language translation to Go championships, was immediately preceded not by an algorithmic innovation but by a massive, well-controlled, purpose-built dataset. An ML-driven breakthrough in medicinal chemistry is going to require a similar dataset, but such high-quality, well-structured experimental data doesn’t exist yet. We're building that data set by making physical measurements of lots of targets (with automated in-house protein production) screened against lots of compounds (with DNA-encoded chemical libraries). We're also building the ML models, that will eventually be generalizable across any protein and novel medicines using insights from our models.
Location: United States, Utah, Salt Lake City
Employees: 1-10
Total raised: $9.3M
Founded date: 2021
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.04.2024 | Seed | $9.3M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 08.04.2024 | Leash Biosciences Raises $9.3M in Seed Financing | Leash Biosciences, a Salt Lake City, UT-based artificial intelligence and machine learning (AI/ML)-n... | finsmes.co... |
| - | Leash Biosciences | “We're transforming drug design with a rich dataset built by screening millions of compounds against... | fastfounde... |